102
Participants
Start Date
June 12, 2018
Primary Completion Date
February 6, 2020
Study Completion Date
August 2, 2022
tisotumab vedotin
All patients will be treated with tisotumab vedotin once every three weeks until progression or toxicity
Cliniques universitaires Saint-Luc, Brussels
Rigshospitalet, Copenhagen
UZLeuvenGynaecologische oncologie, Leuven
CHC SAINT Montlegia, Liège
CHU de LIEGE/ Oncologie Médicale, domaine universitaire du Sart Tilman, Liège
CHU UCL Namur site de Sainte Elisabeth, Namur
Grand Hôpital de Charleroi, Charleroi
Centre Hospitalier de l'Ardenne, Libramont
AZ Sint-Jan Brugge-Oostende av, Bruges
Algemeen Ziekenhuis Maria MiddelaresMedical Oncology - IKG, Ghent
Universitair Ziekenhuis Gent, Ghent
Aalborg Universitetshospital, Aalborg
Vseobecna fakultni nemocnice v Praze, Prague
Hospital Teresa Herrera-CHUAC, A Coruña
Nemocnice Na Bulovce, Gynekologicko-porodnicka kl, Prague
Abington Memorial Hospital, Willow Grove
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Universitaetsklinikum Hamburg-Eppendorf, Hamburg
Skåne University Hospital, Lund
Clínica Universidad de Navarra (Sede Madrid), Madrid
Hospital Clínico San Carlos, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario La Paz, Edificio dotacional de Oncología, Madrid
Bon Secours Saint Francis Cancer Center, Greenville
University of Gynecologic Oncology, Atlanta
Southern Baptist Hospital of Florida, Inc, Jacksonville
University of Miami Miller School of Medicine, Miami
University of Alabama, Birmingham
Policlinico S.Orsola-Malpighi, SSD Oncologia Medica Addarii, Bologna
Louisville Oncology, Louisville
The Ohio State University Wexner Medical Center, Hilliard
Kliniken Essen-Mitte, Düsseldorf
University of Cincinnati, Cincinnati
Community Hospital East, Indianapolis
Froedtert & Medical College Clinics, Milwaukee
Fakultni Nemocnice Brno, Brno
Stephenson Cancer Center, Oklahoma City
Oklahoma Cancer Specialists and Research Institute, LLC, Tulsa
UT Health McGovern Medical School, Houston
Fakultni nemocnice Olomouc Onkologic, Olomouc
Istituto Nazionale Tumori Fondazione G. Pascale, Naples
Klinikum der Universität München, Münich
Arizona Oncology Associate - Biltmore Cancer Center, Phoenix
University of New Mexico Comprehensive Cancer Center (UNMCCC), Albuquerque
Women's Cancer Center of Nevada, Las Vegas
UCLA Dept. of OBGYN, Los Angeles
Baystate Medical Center, Springfield
MD Anderson Cancer Center at Cooper University Hospital, Camden
Irst Irccs, Meldola
Policlinico Universitario Agostino Gemelli, UOC Patologia Ostetrica e Ginecologica, Rome
Hospital Clinic Barcelona, Barcelona
Hospital Duran I Reynals ICO Hospitalet, L'Hospitalet de Llobregat
Fundacion Hospital Son Llatzer, Palma de Mallorca
Collaborators (1)
Genmab
INDUSTRY
European Network of Gynaecological Oncological Trial Groups (ENGOT)
OTHER
Belgian Gynaecological Oncology Group
OTHER
Gynecologic Oncology Group
NETWORK
Seagen Inc.
INDUSTRY